Upgrade to SI Premium - Free Trial

Relay Therapeutics (RLAY) PT Raised to $21 at Wells Fargo

April 28, 2026 5:24 AM
Wells Fargo analyst Eva Fortea Verdejo raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $21.00 (from $17.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change